Delivery Order 75D30123D15974-75D30124F00003
Award Date
9/23/24
Potential Completion Date
5/9/25
Potential Value
$5.6M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,863,965 firm fixed price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the University of Alabama at Birmingham (UAB) to provide Sexually Transmitted Infections Impact Research Consortium (STIIRC) support services. The contract does not have a set-aside designation. Under this order, UAB will coordinate the STIIRC research study, which involves conducting formative qualitative and quantitative research, developing marketing materials, recruiting...
This $7,764,064.96 federal contract was awarded by the Centers for Disease Control and Prevention (CDC) to the University of Alabama at Birmingham (UAB) to provide STIIRC (Sexually Transmitted Infections Impact Research Consortium) support services. The contract is a delivery order under a larger master Indefinite Delivery Contract (IDC) named "Sexually Transmitted Infections Impact Research Consortium Support Services." This contract does not have a set-aside designation. The contract...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Alabama at Birmingham (UAB) for administrative, project management, and overall support of tasks and functions associated with the operation of the Sexually Transmitted Infections Clinical Trials Group (STI CTG). The $1,118,004.79 cost-type delivery order does not have a set-aside designation. UAB, a prominent public research university, serves as the prime...
This $927,885.48 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health to the University of Alabama at Birmingham to conduct a randomized controlled trial comparing the effectiveness of azithromycin versus doxycycline for treating rectal chlamydia in men who have sex with men. The contract has no set-aside designation. The University of Alabama at Birmingham has served as the prime contractor, with sub-awards issued to Family Health...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) for overall administrative and support activities for the Sexually Transmitted Infections Clinical Trials Group (STI CTG). The contract has a ceiling value of $638,457.38 and a period of performance through March 27, 2018. The contract is a delivery order without a set-aside designation. Key...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham (UAB) on September 19, 2018. The $1,435,602.58 delivery order contract supports the Sexually Transmitted Infections Clinical Trials Group and does not have a set-aside designation. Under this contract, UAB is serving as the prime contractor to develop a protocol and complete a Phase 2...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to the University of Alabama at Birmingham (UAB) to study Mycoplasma genitalium infections among men with urethritis attending STD clinics in the U.S. The $2,278,012.40 contract has a period of performance through August 31, 2019 and does not have a set-aside designation. UAB is the prime contractor, with several universities serving as...
This is a Cost No Fee delivery order contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham (UAB), a public research university. The $1,670,687.20 contract is for the Sexually Transmitted Infections Clinical Trials Group and does not have a set-aside designation. The major subcontractors are The Johns Hopkins University, a private research university, and Family Health International (FHI 360), a...
This is a $512,590.94 federal contract award by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the University of Alabama at Birmingham (UAB), a non-profit educational institution. The contract, titled BAA 2017, is a definitive, cost-no-fee contract with a completion date of April 30, 2019. The purpose is to obtain and store clinical diagnostic specimens positive for Mycoplasma pneumoniae (Mp) from a broad geographic area using molecular methods,...
This is a definitized cost-type contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of Alabama at Birmingham (UAB) for a study of commercially available diagnostics. The contract has a potential value of $443,826.00 and a completion date of December 31, 2019. UAB is a public research university known for its innovative and interdisciplinary approach to education. The university has experience providing various goods and...